Ebbing P. de Jong

Ebbing P. de Jong

Auto-generated profile, based on publicly available information

Ebbing P. de Jong

Mass Spectrometry Core Facility

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EJEbbing P. de Jong
Ebbing P. de Jong
HXHongwei Xie
Hongwei Xie
GOGetiria Onsongo
Getiria Onsongo
MSMatthew D. Stone
Matthew D. Stone
XCXiao-Bing Chen
Xiao-Bing Chen
TGTim J Griffin
Tim J Griffin
Oral cancer survival rates increase significantly when it is detected and treated early. Unfortunately, clinicians now lack tests which easily and reliably distinguish pre-malignant oral lesions from those already transitioned to malignancy. A test for proteins, ones found in non-invasively-collected whole saliva and whose abundances distinguish these lesion types, would meet this critical need. To discover such proteins, in a first-of-its-kind study we used advanced mass spectrometry-based quantitative proteomics analysis of the pooled soluble fraction of whole saliva from four subjects with pre-malignant lesions and four with malignant lesions. We prioritized candidate biomarkers via bioinformatics and validated selected proteins by western blotting. Bioinformatic analysis of differentially abundant proteins and initial western blotting revealed increased abundance of myosin and actin in patients with malignant lesions. We validated those results by additional western blotting of individual whole saliva samples from twelve other subjects with pre-malignant oral lesions and twelve with malignant oral lesions. Sensitivity/specificity values for distinguishing between different lesion types were 100%/75% (p = 0.002) for actin, and 67%/83% (p<0.00001) for myosin in soluble saliva. Exfoliated epithelial cells from subjects' saliva also showed increased myosin and actin abundance in those with malignant lesions, linking our observations in soluble saliva to abundance differences between pre-malignant and malignant cells. Salivary actin and myosin abundances distinguish oral lesion types with sensitivity and specificity rivaling other non-invasive oral cancer tests. Our findings provide a promising starting point for the development of non-invasive and inexpensive salivary tests to reliably detect oral cancer early.

1 March 2008 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
HXHongwei Xie
Hongwei Xie
GOGetiria Onsongo
Getiria Onsongo
JPJonathan Popko
Jonathan Popko
EJEbbing P. de Jong
Ebbing P. de Jong
JCJing Cao
Jing Cao
TGTim J Griffin
Tim J Griffin
Whole human saliva possesses tremendous potential in clinical diagnostics, particularly for conditions within the oral cavity such as oral cancer. Although many have studied the soluble fraction of whole saliva, few have taken advantage of the diagnostic potential of the cells present in saliva, and none have taken advantage of proteomics capabilities for their study. We report on a novel proteomics method with which we characterized for the first time cells contained in whole saliva from patients diagnosed with oral squamous cell carcinoma. Our method uses three dimensions of peptide fractionation, combining the following steps: preparative IEF using free flow electrophoresis, strong cation exchange step gradient chromatography, and microcapillary reverse-phase liquid chromatography. We determined that the whole saliva samples contained enough cells, mostly exfoliated epithelial cells, providing adequate amounts of total protein for proteomics analysis. From a mixture of four oral cancer patient samples, the analysis resulted in a catalogue of over 1000 human proteins, each identified from at least two peptides, including numerous proteins with a role in oral squamous cell carcinoma signaling and tumorigenesis pathways. Additionally proteins from over 30 different bacteria were identified, some of which putatively contribute to cancer development. The combination of preparative IEF followed by strong cation exchange chromatography effectively fractionated the complex peptide mixtures despite the closely related physiochemical peptide properties of these separations (pI and solution phase charge, respectively). Furthermore compared with our two-step method combining preparative IEF and reverse-phase liquid chromatography, our three-step method identified significantly more cellular proteins while retaining higher confidence protein identification enabled by peptide pI information gained through IEF. Thus, for detecting salivary markers of oral cancer and possibly other conditions of the oral cavity, the results confirm both the potential of analyzing the cells in whole saliva and doing so with our proteomics method.

15 June 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
JCJae-Woong Chang
Jae-Woong Chang
WZWei Zhang
Wei Zhang
HYHsin-Sung Yeh
Hsin-Sung Yeh
EJEbbing P. de Jong
Ebbing P. de Jong
SJSemo Jun
Semo Jun
JYJeongsik Yong
Jeongsik Yong
Mammalian target of rapamycin (mTOR) enhances translation from a subset of messenger RNAs containing distinct 5′-untranslated region (UTR) sequence features. Here we identify 3′-UTR shortening of mRNAs as an additional molecular signature of mTOR activation and show that 3′-UTR shortening enhances the translation of specific mRNAs. Using genetic or chemical modulations of mTOR activity in cells or mouse tissues, we show that cellular mTOR activity is crucial for 3′-UTR shortening. Although long 3′-UTR-containing transcripts minimally contribute to translation, 3-′UTR-shortened transcripts efficiently form polysomes in the mTOR-activated cells, leading to increased protein production. Strikingly, selected E2 and E3 components of ubiquitin ligase complexes are enriched by this mechanism, resulting in elevated levels of protein ubiquitination on mTOR activation. Together, these findings identify a previously uncharacterized role for mTOR in the selective regulation of protein synthesis by modulating 3′-UTR length of mRNAs.

20 November 2011 in Clinica Chimica Acta
Verified
Journal Article
Closed access
EJEbbing P. de Jong
Ebbing P. de Jong
SRSusan K. van Riper
Susan K. van Riper
JKJoseph S. Koopmeiners
Joseph S. Koopmeiners
JCJohn V. Carlis
John V. Carlis
TGTim J Griffin
Tim J Griffin

31 October 2013 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
VTV Thumbigere‐Math
V Thumbigere‐Math
BMBs Michalowicz
Bs Michalowicz
EJEp de Jong
Ep de Jong
TGTj Griffin
Tj Griffin
DBDl Basi
Dl Basi
RGR Gopalakrishnan
R Gopalakrishnan

5 September 2012 in Journal of Proteome Research
Verified
Journal Article
Closed access
EJEbbing P. de Jong
Ebbing P. de Jong
TGTim J Griffin
Tim J Griffin